Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway

References

• Hua X, Yokoyama C, Wu J, et al. SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc Natl Acad Sci USA. 1993;90:11603–11607.
   PubMed Web of Science ®Google Scholar
• Yokoyama C, Wang X, Briggs MR, et al. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 1993;75:187–197.
   PubMed Web of Science ®Google Scholar
• Rawson RB, Zelenski NG, Nijhawan D, et al. Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. Mol Cell. 1997;1:47–57.
   PubMed Web of Science ®Google Scholar
• Sakai J, Rawson RB, Espenshade PJ, et al. Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells. Mol Cell. 1998;2:505–514.
   PubMed Web of Science ®Google Scholar
• Briggs MR, Yokoyama C, Wang X, et al. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. J Biol Chem. 1993;268:14490–14496.
   PubMed Web of Science ®Google Scholar
• Moon YA, Liang G, Xie X, et al. The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. Cell Metab. 2012;15:240–246.
   PubMed Web of Science ®Google Scholar
• Tang JJ, Li JG, Qi W, et al. Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. Cell Metab. 2011;13:44–56.
   PubMed Web of Science ®Google Scholar
• Kamisuki S, Mao Q, Abu-Elheiga L, et al. A small molecule that blocks fat synthesis by inhibiting the activation of SREBP. Chem Biol. 2009;16:882–892.
   PubMedGoogle Scholar
• Radhakrishnan A, Ikeda Y, Kwon HJ, et al. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to INSIG. Proc Natl Acad Sci USA. 2007;104:6511–6518.
   PubMed Web of Science ®Google Scholar
• Adams CM, Reitz J, De Brabander JK, et al. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and INSIGS. J Biol Chem. 2004;279:52772–52780.
   PubMed Web of Science ®Google Scholar
• Watanabea M, Uesugi M. Small-molecule inhibitors of SREBP activation – potential for new treatment of metabolic disorders. Med Chem Commun. 2013;4:12.
   Google Scholar
• Devries-Seimon T, Li Y, Yao PM, et al. Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor. J Cell Biol. 2005;171:61–73.
   PubMed Web of Science ®Google Scholar
• Hager L, Li L, Pun H, et al. Lecithin:cholesterolacyltransferase deficiency protects against cholesterol-induced hepatic endoplasmic reticulum stress in mice. J Biol Chem. 2012;287:20755–20768.
   PubMed Web of Science ®Google Scholar
• Sozen E, Ozer NK. Impact of high cholesterol and endoplasmic reticulum stress on metabolic diseases: an updated mini-review. Redox Biol. 2017;12:456–461.
   PubMed Web of Science ®Google Scholar
• Feng B, Yao PM, Li Y, et al. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol. 2003;5:781–792.
   PubMed Web of Science ®Google Scholar
• Sekiya M, Yamamuro D, Ohshiro T, et al. Absence of nceh1 augments 25-hydroxycholesterol-induced ER stress and apoptosis in macrophages. J Lipid Res. 2014;55:2082–2092.
   PubMed Web of Science ®Google Scholar
• Okada K, Minamino T, Tsukamoto Y, et al. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation. 2004;110:705–712.
   PubMed Web of Science ®Google Scholar
• Ozcan U, Cao Q, Yilmaz E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004;306:457–461.
   PubMed Web of Science ®Google Scholar
• Bozaykut P, Sahin A, Karademir B, et al. Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic steatohepatitis. Mech Ageing Dev. 2016;157:17–29.
   PubMed Web of Science ®Google Scholar
• Repa JJ, Mangelsdorf DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol. 2000;16:459–481.
   PubMed Web of Science ®Google Scholar
• Joseph SB, McKilligin E, Pei L, et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA. 2002;99:7604–7609.
   PubMed Web of Science ®Google Scholar
• Repa JJ, Berge KE, Pomajzl C, et al. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem. 2002;277:18793–18800.
   PubMed Web of Science ®Google Scholar
• Venkateswaran A, Laffitte BA, Joseph SB, et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci USA. 2000;97:12097–12102.
   PubMed Web of Science ®Google Scholar
• Terasaka N, Hiroshima A, Koieyama T, et al. T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-de¢cient mice. FEBS Lett. 2003;536:6.
   PubMed Web of Science ®Google Scholar
• Song C, Hiipakka RA, Liao S. Auto-oxidized cholesterol sulfates are antagonistic ligands of liver X receptors: implications for the development and treatment of atherosclerosis. Steroids. 2001;66:473–479.
   PubMed Web of Science ®Google Scholar
• Jafari R, Almqvist H, Axelsson H, et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc. 2014;9:2100–2122.
   PubMed Web of Science ®Google Scholar
• Martinez Molina D, Jafari R, Ignatushchenko M, et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science. 2013;341:84–87.
   PubMed Web of Science ®Google Scholar
• Martinez Molina D, Nordlund P. The cellular thermal shift assay: a novel biophysical assay for in situ drug target engagement and mechanistic biomarker studies. Annu Rev Pharmacol Toxicol. 2016;56:141–161.
   PubMed Web of Science ®Google Scholar
• Wang J, Shi ZQ, Xu X, et al. Triptolide inhibits amyloid-beta production and protects neural cells by inhibiting CXCR2 activity. J Alzheimers Dis. 2013;33:217–229.
   PubMed Web of Science ®Google Scholar
• Jerabek-Willemsen M, Wienken CJ, Braun D, et al. Molecular interaction studies using microscale thermophoresis. Assay Drug Dev Technol. 2011;9:342–353.
   PubMed Web of Science ®Google Scholar
• Wienken CJ, Baaske P, Rothbauer U, et al. Protein-binding assays in biological liquids using microscale thermophoresis. Nat Commun. 2010;1:100.
   PubMed Web of Science ®Google Scholar
• Gong X, Li J, Shao W, et al. Structure of the WD40 domain of SCAP from fission yeast reveals the molecular basis for SREBP recognition. Cell Res. 2015;25:401–411.
   PubMed Web of Science ®Google Scholar
• Radhakrishnan A, Sun LP, Kwon HJ, et al. Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain. Mol Cell. 2004;15:259–268.
   PubMed Web of Science ®Google Scholar
• Zheng ZG, Zhou YP, Zhang X, et al. Anhydroicaritin improves diet-induced obesity and hyperlipidemia and alleviates insulin resistance by suppressing SREBPs activation. Biochem Pharmacol. 2016;122:42–61.
   PubMed Web of Science ®Google Scholar
• Ye J, Rawson RB, Komuro R, et al. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell. 2000;6:1355–1364.
   PubMed Web of Science ®Google Scholar
• Zheng ZG, Zhang X, Liu XX, et al. Inhibition of HSP90β improves lipid disorders by promoting mature SREBPs degradation via the ubiquitin-proteasome system. Theranostics. 2019;9:5769–5783.
   PubMed Web of Science ®Google Scholar
• Dasari B, Prasanthi JR, Marwarha G, et al. The oxysterol 27-hydroxycholesterol increases beta-amyloid and oxidative stress in retinal pigment epithelial cells. BMC Ophthalmol. 2010;10:22.
   PubMed Web of Science ®Google Scholar
• Krycer JR, Sharpe LJ, Luu W, et al. The Akt-SREBP nexus: cell signaling meets lipid metabolism. Trends Endocrinol Metab. 2010;21:268–276.
   PubMed Web of Science ®Google Scholar
• Salvado L, Palomer X, Barroso E, et al. Targeting endoplasmic reticulum stress in insulin resistance. Trends Endocrinol Metab. 2015;26:438–448.
   PubMed Web of Science ®Google Scholar
• Asano L, Watanabe M, Ryoden Y, et al. Vitamin D metabolite, 25-hydroxyvitamin D, regulates lipid metabolism by inducing degradation of SREBP/SCAP. Cell Chem Biol. 2017;24:207–217.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell. 2010;140:313–326.
   PubMed Web of Science ®Google Scholar
• Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science. 2004;306:990–995.
   PubMed Web of Science ®Google Scholar
• Mauvezin C, Neufeld TP. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion. Autophagy. 2015;11:1437–1438.
   PubMed Web of Science ®Google Scholar
• Pfister MF, Ruf I, Stange G, et al. Parathyroid hormone leads to the lysosomal degradation of the renal type II Na/Pi cotransporter. Proce Proc Natl Acad Sci USA. 1998;95:1909–1914.
   PubMed Web of Science ®Google Scholar
• Kimura S, Noda T, Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy. 2007;3:452–460.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2016;12:1–222.
   PubMed Web of Science ®Google Scholar
• Roy M, Liang L, Xiao X, et al. Lycorine downregulates HMGB1 to inhibit autophagy and enhances bortezomib activity in multiple myeloma. Theranostics. 2016;6:2209–2224.
   PubMed Web of Science ®Google Scholar
• Kornfeld S. Trafficking of lysosomal enzymes. Faseb J. 1987;1:462–468.
   PubMed Web of Science ®Google Scholar
• Shao W, Espenshade PJ. Sterol regulatory element-binding protein (SREBP) cleavage regulates Golgi-to-endoplasmic reticulum recycling of SREBP cleavage-activating protein (SCAP). J Biol Chem. 2014;289:7547–7557.
   PubMed Web of Science ®Google Scholar
• Sahu R, Kaushik S, Clement CC, et al. Microautophagy of cytosolic proteins by late endosomes. Dev Cell. 2011;20:131–139.
   PubMed Web of Science ®Google Scholar
• Morozova K, Clement CC, Kaushik S, et al. Structural and biological interaction of hsc-70 protein with phosphatidylserine in endosomal microautophagy. J Biol Chem. 2016;291:18096–18106.
   PubMed Web of Science ®Google Scholar
• Tekirdag K, Cuervo AM. Chaperone-mediated autophagy and endosomal microautophagy: joint by a chaperone. J Biol Chem. 2018;293:5414–5424.
   PubMed Web of Science ®Google Scholar
• Fregno I, Fasana E, Bergmann TJ, et al. ER-to-lysosome-associated degradation of proteasome-resistant ATZ polymers occurs via receptor-mediated vesicular transport. Embo J. 2018;37(17):e99259.
   Web of Science ®Google Scholar
• Tekirdag K, Cuervo AM. Chaperone-mediated autophagy and endosomal microautophagy: jointed by a chaperone. J Biol Chem. 2018;293:5414–5424.
   PubMed Web of Science ®Google Scholar
• Sun LP, Li L, Goldstein JL, et al. Insig required for sterol-mediated inhibition of Scap/SREBP binding to COPII proteins in vitro. J Biol Chem. 2005;280:26483–26490.
   PubMed Web of Science ®Google Scholar
• Shao W, Machamer CE, Espenshade PJ. Fatostatin blocks ER exit of SCAP but inhibits cell growth in a SCAP-independent manner. J Lipid Res. 2016;57:1564–1573.
   PubMed Web of Science ®Google Scholar
• Su L, Zhou L, Chen FJ, et al. Cideb controls sterol-regulated ER export of SREBP/SCAP by promoting cargo loading at ER exit sites. Embo J. 2019;38(8):e100156.
   Web of Science ®Google Scholar
• Stephens DJ, Lin-Marq N, Pagano A, et al. COPI-coated ER-to-Golgi transport complexes segregate from COPII in close proximity to ER exit sites. J Cell Sci. 2000;113:2177–2185.
   PubMed Web of Science ®Google Scholar
• Xiao C, Srinivasan R, Drenan RM, et al. Characterizing functional α6β2 nicotinic acetylcholine receptors in vitro: mutant β2 subunits improve membrane expression, and fluorescent proteins reveal responsive cells. Biochem Pharmacol. 2011;82:852–861.
   PubMed Web of Science ®Google Scholar
• Birgisdottir ÅB, Lamark T, Johansen T. The LIR motif–crucial for selective autophagy. J Cell Sci. 2013;126:3237–3247.
   PubMed Web of Science ®Google Scholar
• Otto J, Ordovas JM, Smith D, et al. Lovastatin inhibits diet-induced atherosclerosis in F1b Golden Syrian-Hamsters. Atherosclerosis. 1995;114:19–28.
   PubMed Web of Science ®Google Scholar
• Lebeau P, Al-Hashimi A, Sood S, et al. Endoplasmic reticulum stress and Ca2+ depletion differentially modulate the sterol regulatory protein PCSK9 to control lipid metabolism. J Biol Chem. 2017;292:1510–1523.
   PubMed Web of Science ®Google Scholar
• Yoshida H. ER stress and diseases. Febs J. 2007;274:630–658.
   PubMed Web of Science ®Google Scholar
• Brovkovych V, Izhar Y, Danes JM, et al. Fatostatin induces pro- and anti-apoptotic lipid accumulation in breast cancer. Oncogenesis. 2018;7:66.
   PubMed Web of Science ®Google Scholar
• Kuan YC, Hashidume T, Shibata T, et al. Heat shock protein 90 modulates lipid homeostasis by regulating the stability and function of sterol regulatory element-binding protein (SREBP) and SREBP cleavage-activating protein. J Biol Chem. 2017;292:3016–3028.
   PubMed Web of Science ®Google Scholar
• Birgisdottir AB, Lamark T, Johansen T. The LIR motif-crucial for selective autophagy. J Cell Sci. 2013;126:3237–3247.
   PubMed Web of Science ®Google Scholar
• Pankiv S, Clausen TH, Lamark T, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282:24131–24145.
   PubMed Web of Science ®Google Scholar
• Puvirajesinghe TM, Bertucci F, Jain A, et al. Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer. Nat Commun. 2016;7:10318.
   PubMed Web of Science ®Google Scholar
• Mrschtik M, Ryan KM. Lysosomal proteins in cell death and autophagy. Febs J. 2015;282:1858–1870.
   PubMed Web of Science ®Google Scholar
• Komatsu M, Waguri S, Koike M, et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell. 2007;131:1149–1163.
   PubMed Web of Science ®Google Scholar
• Liu WJ, Ye L, Huang WF, et al. p62 links the autophagy pathway and the ubiqutin–proteasome system upon ubiquitinated protein degradation. Cell Mol Biol Lett. 2016;21:29.
   PubMed Web of Science ®Google Scholar
• Jadhav T, Geetha T, Jiang J, et al. Identification of a consensus site for TRAF6/p62 polyubiquitination. Biochem Biophys Res Commun. 2008;371:521–524.
   PubMed Web of Science ®Google Scholar
• An S, Fu L. Small-molecule PROTACs: an emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018;36:553–562.
   PubMed Web of Science ®Google Scholar
• Chi KR. Drug developers delve into the cell’s trash-disposal machinery. Nat Rev Drug Discov. 2016;15:295–297.
   PubMed Web of Science ®Google Scholar
• Banik S, Pedram K, Wisnovsky S, et al. Lysosome targeting chimeras (LYTACs) for the degradation of secreted and membrane proteins. ChemRxiv. 2019. DOI:https://doi.org/10.26434/CHEMRXIV.7927061.V2.
   Google Scholar
• Goldstein JL, Brown MS. The LDL receptor. Arterioscler Thromb Vasc Biol. 2009;29:431–438.
   PubMed Web of Science ®Google Scholar
• Kita T, Brown MS, Goldstein JL. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase. J Clin Invest. 1980;66:1094–1100.
   PubMed Web of Science ®Google Scholar
• Singer II, Kawka DW, Kazazis DM, et al. Hydroxymethylglutaryl-coenzyme A reductase-containing hepatocytes are distributed periportally in normal and mevinolin-treated rat livers. Proce Proc Natl Acad Sci USA. 1984;81:5556–5560.
   PubMed Web of Science ®Google Scholar
• Chen K, Zeng J, Xiao H, et al. Regulation of glucose metabolism by p62/SQSTM1 through HIF1α. J Cell Sci. 2016;129:817–830.
   PubMed Web of Science ®Google Scholar
• Niu MM, Qin JY, Tian CP, et al. Tubulin inhibitors: pharmacophore modeling, virtual screening and molecular docking. Acta Pharmacol Sin. 2014;35:967–979.
   PubMed Web of Science ®Google Scholar